Buyer landscape

Likely buyers · Pharma in Switzerland.

Prepared 2026-08-28 with GP Intel · deterministic scoring, published weights: gp-intel.com/methodology/league-tables

How companies like this sold · 44 verified exits: 11% to sponsors, 73% to corporates and platforms, 14% via IPO, 2% other routes. Route shift since 2020: sponsors 23% (was 30%), corporates and platforms 67% (was 54%), IPO 8% (was 15%) (sector-wide).

The list: 25 Tier 1 · 0 Tier 2 of 120 matched buyers, including 5 geographic expansion candidates without a local platform yet. A first round of the Tier 1 names plus the expansion buyers covers the demonstrated demand.

Financial buyers · 25

Tier 1 · Very High · score 70+

1. Archimedes Partners SponsorVery High87

53 platform investments in Healthcare · 2 in Switzerland · 21 deals 2024–26

AUM €9.0B · MED Rise · 2024 vintage · deploying · check €8-60M

18 platform investments since the 2024 vintage · largely deployed vs its usual 9 per fund.

Backed IRAB, 2026 · Pharma, Spain

2. ARCHIMED and Institut Mérieux SponsorVery High86

54 platform investments in Healthcare · 2 in Switzerland · 19 deals 2024–26

AUM €9.0B · MED Rise · 2024 vintage · deploying · check €8-60M

18 platform investments since the 2024 vintage · largely deployed vs its usual 9 per fund.

Backed IRAB, 2026 · Pharma, Spain

3. ArchiMed SponsorVery High85

56 platform investments in Healthcare · 2 in Switzerland · 18 deals 2024–26

AUM €9.0B · MED Rise · 2024 vintage · deploying · check €8-60M

18 platform investments since the 2024 vintage · largely deployed vs its usual 9 per fund.

Backed IRAB, 2026 · Pharma, Spain

4. ArchiMed and Tethys Invest SponsorVery High85

54 platform investments in Healthcare · 2 in Switzerland · 18 deals 2024–26

AUM €9.0B · MED Rise · 2024 vintage · deploying · check €8-60M

18 platform investments since the 2024 vintage · largely deployed vs its usual 9 per fund.

Backed IRAB, 2026 · Pharma, Spain

5. capiton VI SponsorVery High82

13 platform investments in Healthcare · 8 in Switzerland · 3 deals 2024–26

AUM €1.6B · capiton Quantum · 2023 vintage · deploying · check €5-37M

4 platform investments since the 2023 vintage · mid-deployment vs its usual 7 per fund.

Bought Dec Group from capiton, 2025 · Pharma, Switzerland

6. NORD Holding SponsorVery High81

15 platform investments in Healthcare · 1 in Switzerland · 15 deals 2024–26

AUM €5.0B · NORD Holding all inclusive Fitness Continuation Fund · 2026 vintage · deploying

Accelerating: 13 deals in the last 2 years vs 2.5/yr before.

Backed NEC MED PHARMA GmbH, 2016 · Pharma, Germany

7. Bpifrance Investissement SponsorVery High80

10 platform investments in Healthcare · 35 deals 2024–26

AUM €57.3B · Bpifrance Amorçage Industriel · 2023 vintage · deploying · check €1-8M

Accelerating: 30 deals in the last 2 years vs 4.5/yr before.

Backed Biogaran, 2026 · Pharma, France

8. SHS Gesellschaft für Beteiligungsmanagement SponsorVery High80

37 platform investments in Healthcare · 6 in Switzerland · 6 deals 2024–26

SHS VI · 2022 vintage · partially deployed · check €5-41M

12 platform investments since the 2022 vintage · largely deployed vs its usual 8 per fund.

Backed AMW, 2026 · Pharma, Germany

9. Armira SponsorVery High80

6 platform investments in Healthcare · 2 in Switzerland · 12 deals 2024–26

AUM €5.0B · Armira III · 2025 vintage · deploying · check €20-150M

8 platform investments since the 2025 vintage · mid-deployment vs its usual 10 per fund.

Backed almapharm, 2024 · Pharma, Germany

10. BC Partners SponsorVery High79

19 platform investments in Healthcare · 1 in Switzerland · 5 deals 2024–26

AUM €40.0B · BC Partners XII · 2025 vintage · deploying · check €44-330M

5 platform investments since the 2025 vintage · early in deployment vs its usual 12 per fund.